Vaccine Responses in Congenital Cytomegalovirus Infection

Area of Science:

• Pediatric Infectious Diseases
• Immunology
• Vaccinology

Background:

• Congenital cytomegalovirus (cCMV) infection is a common cause of sensorineural hearing loss and developmental delay.
• Limited data exists regarding the impact of cCMV on vaccine immunogenicity in children.
• Understanding vaccine responses in cCMV-infected children is crucial for public health strategies.

Purpose of the Study:

• To evaluate the immune response to diphtheria, tetanus, measles, mumps, and rubella vaccines in children with cCMV.
• To compare antibody levels and vaccine efficacy between children with cCMV and healthy controls.

Main Methods:

• A cohort study involving 6-year-old children diagnosed with cCMV and age-matched controls.
• Measurement of serum antibody concentrations against diphtheria, tetanus, measles, mumps, and rubella antigens.
• Comparison of geometric mean concentrations (GMCs) and the proportion of children achieving protective antibody levels.

Main Results:

• No significant differences were observed in protective antibody levels between children with cCMV and controls.
• Geometric mean concentrations for all studied vaccine antigens were comparable across both groups.
• These findings suggest robust vaccine immunogenicity despite the presence of cCMV infection.

Conclusions:

• Children with congenital cytomegalovirus infection mount adequate immune responses to standard childhood vaccinations.
• Immunization schedules for children with cCMV should follow established national guidelines.
• This supports the safety and efficacy of routine vaccine administration in this population.